Invesaro

Stocks Health care USAQ

OTC · Health care

QHSLab, Inc. (USAQ)

QHSLab, Inc. brought in $3M of revenue over the twelve months to June 30, 2026, up 24.6% from a year earlier. Net income was $524.1K, a net margin of 17.4%. At June 30, 2026 it held $317.4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Watch USAQ in 60 seconds
Price
$0.32
0.00% on the day · September 25, 2026
52-week range $0.16 to $1.14
Market cap
$4.8M
Revenue (last 12 months)
$3M
+24.6% year on year
Net margin
17.4%
P/E
16.0
on FY2025 diluted EPS

What QHSLab, Inc. does

QHSLab, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker USAQ.

Revenue and profit by year

Revenue
FY20: $124.5K $124.5K FY20FY21: $1.4M $1.4M FY21FY22: $1.2M $1.2M FY22FY23: $1.4M $1.4M FY23FY24: $2.1M $2.1M FY24FY25: $2.7M $2.7M FY25
Net income
FY18: -$38.6K -$38.6K FY18FY19: -$166.5K -$166.5K FY19FY20: -$327.4K -$327.4K FY20FY21: -$770.2K -$770.2K FY21FY22: -$996K -$996K FY22FY23: -$468.4K -$468.4K FY23FY24: -$259.2K -$259.2K FY24FY25: $457.4K $457.4K FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$2.7M$131.2K$457.4K$0.02n/a
2024$2.1M$205.7K-$259.2K-$0.03n/a
2023$1.4M-$240.2K-$468.4K-$0.05n/a
2022$1.2M-$560.5K-$996K-$0.11n/a
2021$1.4M-$502.3K-$770.2K-$0.10n/a
2020$124.5K-$275.1K-$327.4K-$0.05n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar

Where USAQ ranks in Health care

Revenue$2.7M
#596 of 742 in Health care · Bottom 20%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What QHSLab, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 17, 2026
  2. September 10, 2026
  3. September 4, 2026
  4. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 40% to $847.5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  5. August 3, 2026
  6. June 17, 2026
  7. May 26, 2026
  8. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 13% to $728.7K versus the same quarter last year; diluted EPS $0.00 versus -$0.01.
  9. April 27, 2026
  10. April 21, 2026

Recent insider filings (Forms 3, 4 and 144): 9, the latest on September 3, 2026. Insider transactions on SEC

Insider trades

What the people running QHSLab, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 26, 2026 Marvin Smollar Family Trust dtd 2/13/202310% owner Other change 2,226,280 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns USAQ

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Nicholas Peters13G, passive 8.65% 1,161,049 February 25, 2026
Jeremy L. Smollar Irrevocable Trust dtd 2/13/202313G, passive with 1 related filers 7.4% 1,113,140 September 17, 2026
Justin B. Smollar Irrevocable Trust dtd 2/13/202313G, passive with 1 related filers 7.4% 1,113,140 September 10, 2026

Latest filings below 5%: Marvin Smollar Family Trust dtd 2/13/2023 0% (September 4, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about USAQ

What does QHSLab, Inc. do?

QHSLab, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker USAQ.

Is QHSLab, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $524.1K on revenue of $3M, a net margin of 17.4%.

How much revenue does QHSLab, Inc. make?

Over the twelve months to June 30, 2026 QHSLab, Inc. reported revenue of $3M. That is 24.6% more than a year earlier.

When did QHSLab, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 17, 2026.

Similar companies

Compare USAQ with

Compare USAQ with any company

Follow USAQ

Get an email when QHSLab, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow USAQ: get an email when it files

Where the numbers come from

Financial figures are the values QHSLab, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.